Seroatlas · Human Serome Atlas

IQCF5

IQ domain-containing protein F5

Also known as: IQCF5_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
A8MTL0
Gene
IQCF5
Ensembl
ENSG00000214681
Chromosome
3
Canonical length
148 aa
Protein class
Predicted membrane proteins

OverviewNCBI Gene

Predicted to enable calmodulin binding activity. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

148 residues, UniProt reviewed canonical sequence.

>A8MTL0|IQCF5
     1  MGPEEKTIMT ERSAAVFIQA WWRGMLVRRT LLHAALRAWI IQCWWRQVLE KLLAKRRRMV
    61  LEFYVQQEWA AVRLQSWVRM WCVRQRYCRL LNAVRIIQVY WRWHSCHSRV FIEGHYELKE
   121  NQLNIQLEIS LGLQACKVQQ CIPLPLKE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IQCF5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.49
Highest tissue expression
96 nTPM

Expression across tissuesHPA

Tissue

  • testis: 96 nTPM
  • adipose tissue: 0 nTPM
  • adrenal gland: 0 nTPM
  • amygdala: 0 nTPM
  • appendix: 0 nTPM
  • basal ganglia: 0 nTPM

Single-cell type

  • late spermatids: 3,725 nCPM
  • early spermatids: 959 nCPM
  • late primary spermatocytes: 393 nCPM
  • leydig cells: 4.9 nCPM
  • sertoli cells: 3.4 nCPM
  • peritubular myoid cells: 1.7 nCPM

Immune cell

  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • cerebral cortex: 0.6 nTPM
  • basal ganglia: 0.4 nTPM
  • white matter: 0.4 nTPM
  • amygdala: 0.2 nTPM
  • cerebellum: 0.2 nTPM
  • hippocampal formation: 0.2 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about IQCF5.

Disease | ImmuneIEDB

Conditions an epitope on IQCF5 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.19
gnomAD pLI
0.01
gnomAD missense Z
0.7
DepMap mean gene effect
-0.07
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Molecular functions

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IQCF5 as an antibody target. Whether an autoantibody or antibody against IQCF5 could matter depends on whether native IQCF5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IQCF5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label IQCF5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IQCF5. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...